跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DOCETAXEL INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DOCETAXEL INJECTION
Authorized
STANDARD
DOCETAXEL INJECTION
biolyse pharma corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ad470f014fb664cb
Company
biolyse pharma corporation
Type
Standard
Approval Details
Approval Id
ad470f014fb664cb
Drug Approval Canada Name
DOCETAXEL INJECTION
Product Name
DOCETAXEL INJECTION
Status
Marketed
Status Date
2017-10-17
Original Market Date
2017-10-17
Din
02458020
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01CD02 DOCETAXEL
Atc Name
l 01 cd 02
Aig Number
0127884004
Company Name
biolyse pharma corporation
Company Address
59 Welland Vale Road, St. Catharines, Ontario, Canada, L2S 3Y2
Active Ingredients
DOCETAXEL
20 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ad470f014fb664cb
Type
Standard
Back to Health Canada Approvals